AcuityMD raises $80 million Series C at a $955 million valuation for medtech sales AI
What Happened
AcuityMD closed an $80 million Series C on April 21 at a $955 million post-money valuation, led by StepStone Group with Benchmark, Redpoint, ICONIQ, and Atreides participating. The company makes AI tools that help medical device sales reps identify which surgeons, hospitals, and procedures match their products. AcuityMD reports it now serves 16 of the top 20 medtech firms.
My Take
This is being filed under "another vertical AI raise." Medical device sales is one of the highest-paid jobs in US healthcare and structurally one of the easiest to automate, because the work is research, scheduling, and follow-up rather than persuasion. AcuityMD's customers will quietly cut quota and headcount as productivity rises, then point to it as a margin story. Prediction: by 2027, medtech rep headcount drops 15% at firms that adopt vertical AI tools, with no corresponding drop in revenue.
Read Original Source